Young‐Woo Jeon

2.1k total citations
146 papers, 1.4k citations indexed

About

Young‐Woo Jeon is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Young‐Woo Jeon has authored 146 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 55 papers in Oncology and 34 papers in Immunology. Recurrent topics in Young‐Woo Jeon's work include Hematopoietic Stem Cell Transplantation (48 papers), Acute Myeloid Leukemia Research (42 papers) and Lymphoma Diagnosis and Treatment (32 papers). Young‐Woo Jeon is often cited by papers focused on Hematopoietic Stem Cell Transplantation (48 papers), Acute Myeloid Leukemia Research (42 papers) and Lymphoma Diagnosis and Treatment (32 papers). Young‐Woo Jeon collaborates with scholars based in South Korea, United States and United Kingdom. Young‐Woo Jeon's co-authors include Seok‐Goo Cho, Ki‐Seong Eom, Seok Lee, Sung‐Eun Lee, Jae‐Ho Yoon, Chang‐Ki Min, Yoo‐Jin Kim, Hee‐Je Kim, Byung‐Sik Cho and Jong Wook Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Young‐Woo Jeon

133 papers receiving 1.4k citations

Peers

Countries citing papers authored by Young‐Woo Jeon

Since Specialization

Citations

This map shows the geographic impact of Young‐Woo Jeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Woo Jeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Woo Jeon more than expected).

Fields of papers citing papers by Young‐Woo Jeon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Woo Jeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Woo Jeon. The network helps show where Young‐Woo Jeon may publish in the future.

Co-authorship network of co-authors of Young‐Woo Jeon

This figure shows the co-authorship network connecting the top 25 collaborators of Young‐Woo Jeon. A scholar is included among the top collaborators of Young‐Woo Jeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young‐Woo Jeon. Young‐Woo Jeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center Retrospective Study 2025 ·Diagnostics ·Dong Hoon Kang, Gi June Min, (unknown), Young‐Woo Jeon, Yu Kyung Cho, Jae Myung Park, Joo Hyun O, Byung‐Ock Choi, Gyeongsin Park, Seok‐Goo Cho	1
2	Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled Study 2024 ·Transplantation and Cellular Therapy ·(unknown), Ja Min Byun, Sung‐Soo Park, (unknown), (unknown), Seung Pil Jung, (unknown), Seunghoon Han, Jung Yeon Lee, Youngil Koh, Young‐Woo Jeon, Seung‐Ah Yahng, Seung‐Hwan Shin, Sung‐Soo Yoon, Chang‐Ki Min	1
3	Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study 2024 ·International Journal of Molecular Sciences ·Nayoun Kim, Gi June Min, Keon-Il Im, Young-Sun Nam, (unknown), (unknown), Eun‐Jee Oh, Nack‐Gyun Chung, Young‐Woo Jeon, Jong Wook Lee, Seok‐Goo Cho	6
4	Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma 2024 ·Cancer Medicine ·(unknown), Tae Jung Kim, Eun Ji Han, Gi June Min, Sung‐Soo Park, (unknown), Jae‐Ho Yoon, Sung‐Eun Lee, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, (unknown), Chang‐Ki Min, Jong Wook Lee, Young‐Woo Jeon, Seok‐Goo Cho	0
5	Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience 2023 ·Annals of Hematology ·Gi June Min, Dong Hoon Kang, Han Hee Lee, (unknown), (unknown), Young‐Woo Jeon, Joo Hyun O, Byung‐Ock Choi, Gyeongsin Park, Seok‐Goo Cho	3
6	Prognostic value of low muscle mass at the 12<sup>th</sup> thoracic vertebral level in multiple myeloma treated with transplantation: CAREMM-2101 study 2023 ·Diagnostic and Interventional Radiology ·Sung‐Soo Park, (unknown), (unknown), Young‐Woo Jeon, Seung‐Ah Yahng, Seung‐Hwan Shin, (unknown), Chang‐Ki Min	1
7	A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea 2023 ·Expert Opinion on Biological Therapy ·Jae‐Cheol Jo, Young‐Woo Jeon, (unknown), Deok‐Hwan Yang, Won Sik Lee, (unknown), Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung‐Yoon Choe, (unknown), (unknown), (unknown), (unknown), (unknown), Seok‐Goo Cho	1
8	Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single‐center real‐world clinical experience 2023 ·Cancer Medicine ·Gi June Min, (unknown), Young‐Woo Jeon, Joo Hyun O, Byung‐Ock Choi, Gyeongsin Park, Young‐Hoon Park, Seok‐Goo Cho	4
9	Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma 2023 ·Cancers ·(unknown), Chae Eun Yang, (unknown), (unknown), Wan-Su Choi, Jung-Yeon Lim, Young‐Woo Jeon	4
10	Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification 2022 ·Cancers ·(unknown), Silvia Park, (unknown), Jong-Hyuk Lee, (unknown), Gi June Min, Sung‐Soo Park, Young‐Woo Jeon, (unknown), Seung‐Ah Yahng, Jae‐Ho Yoon, Sung‐Eun Lee, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Jong‐Wook Lee, Hee‐Je Kim	1
11	Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations 2020 ·PLoS ONE ·Han Hee Lee, Seok‐Goo Cho, In Seok Lee, (unknown), Young‐Woo Jeon, Joo Hyun O, Seung Eun Jung, Byung Ock Choi, (unknown), Suk‐Woo Yang	12
12	Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy 2020 ·PLoS ONE ·Hye Jin Kang, Han Hee Lee, Seung Eun Jung, (unknown), (unknown), Young‐Woo Jeon, Byung‐Ock Choi, Seok‐Goo Cho	9
13	FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings 2020 ·Diagnostics ·Eun Ji Han, Joo Hyun O, Seung Eun Jung, Gyeongsin Park, Byung‐Ock Choi, Young‐Woo Jeon, Gi June Min, Seok‐Goo Cho	11
14	Circulating CD3⁺CD4⁺CD161⁺Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma 2018 ·BioMed Research International ·Sung‐Eun Lee, Ji‐Young Lim, (unknown), Tae‐Woo Kim, Young‐Woo Jeon, Jae‐Ho Yoon, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Seok‐Goo Cho, Dong‐Wook Kim, Jong Wook Lee, Woo-Sung Min, Chang‐Ki Min	3
15	Minimal residual disease–based long‐term efficacy of reduced‐intensity conditioning versus myeloablative conditioning for adult Philadelphia‐positive acute lymphoblastic leukemia 2018 ·Cancer ·Jae‐Ho Yoon, Gi June Min, Sung‐Soo Park, Young‐Woo Jeon, Sung‐Eun Lee, (unknown), Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong Wook Lee, Seok Lee	26
16	Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates 2018 ·Blood ·(unknown), Gi June Min, Hee‐Je Kim, (unknown), Sung‐Soo Park, Silvia Park, Seung‐Ah Yahng, Young‐Woo Jeon, Seung‐Hwan Shin, Jae‐Ho Yoon, Sung‐Eun Lee, Ki‐Seong Eom, Yoo‐Jin Kim, (unknown), (unknown), Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong‐Wook Lee	1
17	Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model 2018 ·Stem Cells and Development ·Young‐Woo Jeon, Jung-Yeon Lim, Keon-Il Im, Nayoun Kim, Young-Sun Nam, (unknown), Seok‐Goo Cho	8
18	Durable Outcomes of a Prospective Double Cord Blood Transplantation Trial in Adults with Acute Lymphoblastic Leukemia: Different Outcomes According to the Presence of Philadelphia Chromosome 2017 ·Blood ·Jae‐Ho Yoon, Sung‐Soo Park, Young‐Woo Jeon, Sung‐Eun Lee, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong‐Wook Lee, Woo-Sung Min, Seok Lee	1
19	Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia 2017 ·Blood Research ·Jae‐Ho Yoon, Hee‐Je Kim, (unknown), Gi June Min, Sung‐Soo Park, Young‐Woo Jeon, Sung‐Eun Lee, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong Wook Lee, Woo-Sung Min	7
20	Molecular and Cytogenetic Risk Stratification For Core-Binding Factor-Positive Adult AML With Analysis Of Post-Remission Treatment Outcomes Including Transplantation 2013 ·Blood ·Jae‐Ho Yoon, Hee‐Je Kim, Seung-Hwan Shin, Young‐Woo Jeon, (unknown), Sung‐Eun Lee, (unknown), Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, (unknown), (unknown), Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong‐Wook Lee, Woo‐Sung Min, Chong-Won Park	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact